NEW YORK, March 28, 2017 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Tempur Sealy International, Inc. (“Tempur Sealy” or the “Company”) (Nasdaq:TPX) in the United States District Court for the Southern District of New York on behalf of a class consisting of investors who purchased or otherwise acquired Tempur Sealy stock on the open market from July 28, 2016 through January 27, 2017, inclusive (the “Class Period”).
The complaint alleges that Tempur Sealy, which develops, manufactures, and distributes bedding products worldwide, and certain of its officers violated the Securities Exchange Act of 1934. Specifically, the complaint alleges that during the Class Period, defendants made materially false and misleading statements and/or failed to disclose adverse information regarding Tempur Sealy’s business and prospects, including, among other things: (i) that prior to and during the Class Period, Mattress Firm Holding Corp. ("Mattress Firm"), the Company’s largest customer which accounted for approximately 25% of the Tempur Sealy's 2015 net sales, had been engaged in active negotiations to be acquired and that any such acquisition was reasonably likely to have a material adverse effect in Tempur Sealy’s 2016 third and fourth quarter operating results; (ii) that during the Class Period, Tempur Sealy was engaged in active discussions with Mattress Firm concerning modifications to their long-term supply agreements; (iii) that Mattress Firm had been seeking significant economic concessions from Tempur Sealy during the Class Period; (iv) that defendants lacked a reasonable basis for the Company’s positive statements associated with Mattress Firm; and (v) that, based on the foregoing, defendants lacked a reasonable basis for their positive statements about Tempur Sealy’s then-current business and future financial prospects.
On January 27, 2017, Tempur Sealy announced that it would cease doing business with Mattress Firm during the first quarter of 2017. In response to this news, the complaint alleges, the price of Tempur Sealy common stock plummeted $20.19 per share over a two-day period, or nearly 32%, to close at $43.00 per share on January 31, 2017.
The complaint further alleges that individual defendants were motivated to engage in the course of conduct alleged therein to allow Company insiders to sell more than $8.2 million of Tempur Sealy common stock at artificially inflated prices during the Class Period.
If you wish to serve as lead plaintiff, you must move the Court no later than May 23, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules 



